Press release
Urinary Tract Infections Therapeutics Pipeline Analysis 2018 by Key Players - Achaogen, AmpliPhi Biosciences Corporation, and Iterum Therapeutics Limited
According to the research findings, a majority of the drug candidates for the treatment of UTIs are being developed as small molecules. It has been observed that the drugs that are being developed as small molecules are easy to manufacture with high production rate.Browse report sample at: https://www.psmarketresearch.com/market-analysis/utis-therapeutics-pipeline/report-sample
It has been observed that a majority of the companies in the UTIs therapeutic pipeline are developing drug candidates by using advanced technologies and these drug candidates have further shown positive efficacy in the clinical stage of development. For instance, MULTIPHORE Drug Design platform developed by Talon Pharmaceuticals Inc., specifies the complexity of the disease in nature. The above-mentioned technology is designed to identify the drug that interacts with multiple disease target through careful incorporation of multiple pharmacophores into a single molecule or through unique combination of different mechanisms of action implicated in the disease state.
The companies involved in the UTIs therapeutic pipeline are developing various drug candidates as combination therapies, that have several advantages such as, improved medication compliance by decreasing the pill burden of patients, increased efficacy, and reduced side effects and cost. For instance, C-Scape, a Phase I drug candidate by Achaogen Inc. is a combination of ceftibuten and clavulanate, that are small molecules obtained from the synthetic source. Both ceftibuten and clavulanate act by different mechanism of action but give synergistic effects. Ceftibuten acts as cell wall synthesis inhibitor and, clavulanate acts as beta-lactamase inhibitor.
Browse report at: https://www.psmarketresearch.com/market-analysis/utis-therapeutics-pipeline
Some of the key players involved in the development of UTIs therapeutics pipeline include Achaogen Inc., AmpliPhi Biosciences Corporation, and Iterum Therapeutics Limited.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urinary Tract Infections Therapeutics Pipeline Analysis 2018 by Key Players - Achaogen, AmpliPhi Biosciences Corporation, and Iterum Therapeutics Limited here
News-ID: 1370997 • Views: …
More Releases from P&S Intelligence

U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…

Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…

Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…

Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for UTIs
Urinary Tract Infection (UTI) Treatment Market to Reach US$ 15.08 Bn by 2032, Re …
Urinary tract infections (UTIs) represent one of the most common bacterial infections affecting individuals across the globe. The treatment market for UTIs has been experiencing significant growth, driven by a combination of factors such as antibiotic resistance, an aging population, and the increasing global awareness about symptoms. With advancements in diagnostic tools and pharmaceutical innovations, the UTI treatment market is expected to continue expanding throughout the next decade. In this…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Set to Reach US$11. …
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
Urinary tract infections (UTIs) are among the most common bacterial infections globally, affecting millions of individuals each year. UTIs are categorized into two types: complicated and uncomplicated. While complicated UTIs tend to be more severe and associated with underlying medical conditions, uncomplicated UTIs are typically simpler to treat and occur in otherwise healthy individuals. The uncomplicated UTI treatment market is witnessing robust growth, with an expected market size reaching…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by…
Ultimate Guide to UTI Prevention and Care for Women Unveiled by All-Inclusive Pr …
Image: https://www.getnews.info/wp-content/uploads/2024/09/1727265867.jpeg
MIAMI LAKES, FLORIDA - September 25, 2024 - All-Inclusive Preventive Care LLC [https://www.allinclusive.care/uti-women/] has released a detailed guide for women on urinary tract infection (UTI) prevention and care. This resource aims to educate women on UTI prevention and offer practical advice on maintaining urinary health.
Urinary tract infections (UTIs) are a common condition that affect millions of women each year. The guide from All-Inclusive Preventive Care explains what a UTI…
Global Automated Urine Particle Analyzer Market Set to Grow at a CAGR of 7.5% fr …
The global Automated Urine Particle Analyzer market is set for substantial growth at a Compound Annual Growth Rate (CAGR) of 7.5% from this year till 2030, according to a latest research report by Dataintelo. The ascendancy of this market is primarily fostered by the escalating prevalence of urinary tract infections (UTIs) paired with the rising demand for point-of-care diagnostics.
The fully automatic segment is anticipated to dominate the market during the…
With 4.56% CAGR, Urinary Tract Infection Therapeutics Market Size Worth USD 11,6 …
Facts and Influences A new report from Market Research is titled "Urinary Tract Infection Therapeutics Market- By Age Group (Children, Adults & Elderly), By Indication (Complicated, Uncomplicated, Recurrent, Catheter-related), By Distribution Network (E-commerce, Hospital Pharmacies, Retail Pharmacies), By Drug Group (Azoles and Amphotericin B, Cephalosporin, Quinolones, Nitrofurans, Penicillin The global market for therapies for urinary tract infections was estimated to be worth USD 8,935 million in 2020 and is projected…